Home › Occupations › Molecular and Cellular Biologists › Pleasanton, CA
Molecular and Cellular Biologists in Pleasanton, CA: H-1B salaries
48 labor condition applications for this occupation with a work site in Pleasanton, CA. Median offered base salary $112,404; middle half $86,193–$140,250.
By wage level
| Wage level | Median salary |
|---|---|
| Level I (entry) | $85,197 |
| Level II (qualified) | $112,258 |
| Level III (experienced) | $140,500 |
| Level IV (fully competent) | $170,000 |
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Employers
| Employer | LCAs | Median salary |
|---|---|---|
| 10x Genomics, Inc. | 13 | $140,000 |
| Thermo Fisher Scientific Inc. | 7 | $85,350 |
| Roche Molecular Systems, Inc. | 6 | $85,197 |
| LifeFoundry, Inc. | 5 | $117,210 |
| Roche Sequencing Solutions, Inc. | 4 | $119,704 |
| Bio-Rad Laboratories, Inc. | 4 | $112,549 |
| CooperVision, Inc. | 2 | $133,020 |
| Place Genomics Corporation | 2 | $170,000 |
| Amador Bioscience, Inc. | 1 | $65,125 |
| DiaCarta, Inc. | 1 | $101,816 |
| Acrobiosystems Inc. | 1 | $107,600 |
| OPM Biosciences Inc. | 1 | $95,000 |
| Promptbio, Inc. | 1 | $150,000 |
Job titles
- Scientist5
- Scientist II, Molecular Biology3
- Research Associate 22
- Senior Scientist2
- Biosystem Scientist2
- Staff Computational Biologist2
- Scientist III, Molecular Biology2
- Senior Staff Scientist2
- Biosystem Research Scientist2
- Biospecimen Senior Specialist2
- Principal Scientist I2
- Statistical Programmer1
- Principal Scientist1
- Computational Biologist 21
- Bioinformatics Scientist II1
H-1B sponsors in Pleasanton, CA →
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).